Status:
UNKNOWN
The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil
Lead Sponsor:
University of Cambridge
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
Sildenafil and similar drugs have been used for several years to treat erectile dysfunction. It has been noticed that in some people, sildenafil causes a subtle increase in the length of time that vis...
Eligibility Criteria
Inclusion
- Healthy
- Male
- 18-55 years
Exclusion
- Significant medical or psychiatric illness
- Cardiac disease
- Hyper or hypotension
- Renal disease
- Liver disease
- Stroke
- Sickle cell anaemia
- Multiple myeloma
- Leukaemia
- Bleeding disorders
- Peyronie's disease
- Priapism
- Subjects receiving prescribed medications
- Subjects with known visual abnormalities other than refractive errors, including retinitis pigmentosa, optic neuropathy
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00463957
Start Date
August 1 2006
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cambridge
Cambridge, United Kingdom